Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.4.2 is now shown, replacing the previous v3.4.1.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision: v3.4.1 introduced as part of the site update; no substantive changes to the page content or its functionality were observed.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check32 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no visible changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded a centralized Locations section with entries for multiple US states and Canadian provinces, and removed the prior separate state/province location pages.SummaryDifference0.6%

- Check83 days agoChange DetectedPublications section text updated to indicate PubMed entries are auto-filled and may not relate to the study, and the page revision was updated to v3.3.2. The older PubMed-source description and the v3.2.0 revision note were removed.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.